Approximately 5 million Americans have dementia, and many receive psychiatric medications. Management of such patients is complex and controversial, and it has become apparent that all potential pharmacological therapies present risks.

Breaking News

Federal financial incentives spur hunt for customers’ perspectives
Panels question ‘existence and magnitude’ of drug’s overall benefit
Treatment OK’d for second-line use with Folfiri in metastatic colorectal cancer
Most states don’t allow basic EMS staff to administer injections
Mid-stage trial fails to meet primary and secondary endpoints

Recent Headlines

Report calls for improved interoperability
Many facilities lack programs to cut use of antibiotics that encourage dangerous gut infection
Niclosamide as effective as vancomycin in early investigation
New Jersey hospital sends medical teams to patients’ homes to coordinate follow-up care